News
-
-
-
PRESS RELEASE
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
Sanofi's venglustat receives Breakthrough Therapy designation in the US for type 3 Gaucher disease, a rare lysosomal storage disorder. Positive results from the LEAP2MONO study show significant improvements in neurological symptoms -
-
-
PRESS RELEASE
Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director
Sanofi's Board of Directors proposes appointment of Christel Heydemann as independent director, renewing mandates, and thanking Patrick Kron. Heydemann brings expertise in industrial and digital transformation, strengthening governance diversity -
-
-
PRESS RELEASE
Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report
Sanofi files amendment to French 'Document d’Enregistrement Universel' with annual financial report, including governance updates. Available on Sanofi and AMF websites -
